Mark Hazeltine
Plus aucun poste en cours
Fortune : 43 720 $ au 31/03/2024
Profil
Mark Hazeltine worked as the Director of Financial Planning & Analysis at CareFusion Corp.
from 2010 to 2015.
He then worked as the Chief Business Officer at Exagen, Inc. from 2022 to 2023.
Hazeltine received his undergraduate degree from the University of San Diego and his MBA from USC Marshall School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
EXAGEN, INC.
0,16% | 18/04/2023 | 27 497 ( 0,16% ) | 43 720 $ | 31/03/2024 |
Anciens postes connus de Mark Hazeltine
| Sociétés | Poste | Fin |
|---|---|---|
| EXAGEN INC. | Chief Operating Officer | 05/12/2022 |
| CAREFUSION CORPORATION | Corporate Officer/Principal | 01/03/2015 |
Formation de Mark Hazeltine
| University of San Diego | Undergraduate Degree |
| USC Marshall School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EXAGEN INC. | Health Services |
| Entreprise privées | 1 |
|---|---|
CareFusion Corp.
 CareFusion Corp. Medical DistributorsDistribution Services CareFusion Corp. engages in the manufactures of medical equipment and device. The company was founded on February 4, 2009 and is headquartered in San Diego, CA. | Distribution Services |
